Nkarta Correlations
NKTX Stock | USD 4.26 0.26 6.50% |
The current 90-days correlation between Nkarta Inc and Monte Rosa Therapeutics is 0.41 (i.e., Very weak diversification). The correlation of Nkarta is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Nkarta Correlation With Market
Weak diversification
The correlation between Nkarta Inc and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and DJI in the same portfolio, assuming nothing else is changed.
Nkarta |
Moving together with Nkarta Stock
0.64 | VALN | Valneva SE ADR | PairCorr |
0.78 | DYAI | Dyadic International | PairCorr |
0.79 | ERNA | Eterna Therapeutics | PairCorr |
0.84 | XFOR | X4 Pharmaceuticals | PairCorr |
0.76 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.9 | PTN | Palatin Technologies | PairCorr |
0.74 | INAB | In8bio Inc | PairCorr |
0.85 | INKT | Mink Therapeutics | PairCorr |
0.78 | MNMD | Mind Medicine | PairCorr |
0.67 | MOLN | Molecular Partners | PairCorr |
0.64 | MRVI | Maravai Lifesciences | PairCorr |
0.82 | ONCT | Oncternal Therapeutics | PairCorr |
0.71 | ABCL | Abcellera Biologics | PairCorr |
0.74 | ABOS | Acumen Pharmaceuticals | PairCorr |
Moving against Nkarta Stock
0.79 | BMY | Bristol Myers Squibb | PairCorr |
0.73 | GNFT | Genfit | PairCorr |
0.67 | A | Agilent Technologies Fiscal Year End 18th of November 2024 | PairCorr |
0.66 | GILD | Gilead Sciences | PairCorr |
0.54 | WVE | Wave Life Sciences | PairCorr |
0.44 | ZURA | Zura Bio Limited | PairCorr |
0.43 | LLY | Eli Lilly | PairCorr |
0.72 | AMLX | Amylyx Pharmaceuticals | PairCorr |
0.65 | BNTX | BioNTech SE | PairCorr |
0.62 | TARS | Tarsus Pharmaceuticals | PairCorr |
0.56 | ABBV | AbbVie Inc | PairCorr |
0.54 | ARDX | Ardelyx | PairCorr |
0.52 | APGE | Apogee Therapeutics, | PairCorr |
0.51 | TCBPW | TC BioPharm plc | PairCorr |
0.42 | SMMT | Summit Therapeutics PLC | PairCorr |
0.38 | ANNX | Annexon | PairCorr |
0.38 | TELO | Telomir Pharmaceuticals, | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nkarta Stock performing well and Nkarta Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nkarta's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GLUE | 4.74 | 0.25 | 0.09 | 0.16 | 4.77 | 11.82 | 34.89 | |||
LYEL | 4.34 | (0.66) | 0.00 | (0.09) | 0.00 | 12.10 | 28.28 | |||
GBIO | 5.06 | (0.57) | 0.00 | (0.03) | 0.00 | 10.42 | 34.63 | |||
SANA | 3.22 | (0.63) | 0.00 | (0.18) | 0.00 | 5.79 | 17.77 | |||
PASG | 4.09 | (0.64) | 0.00 | (0.43) | 0.00 | 8.22 | 19.82 | |||
BDTX | 4.04 | (0.94) | 0.00 | (0.29) | 0.00 | 7.07 | 26.97 | |||
TCRR | 3.16 | 0.56 | 0.07 | (0.18) | 3.26 | 5.77 | 43.60 | |||
HARP | 3.55 | 0.60 | 0.12 | (0.97) | 3.28 | 9.59 | 22.48 | |||
ALEC | 3.61 | (0.40) | 0.00 | (0.05) | 0.00 | 8.87 | 19.87 |
Nkarta Corporate Management
Ralph Brandenberger | Chief Officer | Profile | |
Nadir Mahmood | Chief Officer | Profile | |
Greg Mann | Vice Relations | Profile | |
Yvonne MBA | Chief Officer | Profile | |
Alicia Hager | Chief Secretary | Profile | |
James Trager | Chief Officer | Profile |